← All trials
NCT00415038
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2005
- Primary completion
- Apr 1, 2007
- Completion date
- Aug 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 438
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- Leadiant Biosciences, Inc.Lead sponsor
- U.O. Cardiologia - Ospedale Civile di Schio (Vicenza) ItalyOverall official - principal investigator
- Centro de la Salud de Vistalegre - La Flota, Murcia (Spain)Overall official - principal investigator
- Centro de Salud Murcias San Andres - Murcia (Spain)Overall official - principal investigator
- University of LjubljanaOverall official - principal investigator
- Postgraduate Medical School, WarszawaOverall official - principal investigator
- Maastricht UniversityOverall official - principal investigator
- Russian Academy of Medical SciencesOverall official - principal investigator
- Charles UniversityOverall official - principal investigator
- Poznan UniversityOverall official - principal investigator
- Smolensk State Medical AcademyOverall official - principal investigator
- Hospital de Conxo - Santiago de CompostelaOverall official - principal investigator
- University of SantiagoOverall official - principal investigator
- Hospital de SaguntoOverall official - principal investigator
- University of ValenciaOverall official - principal investigator
- Masaryk UniversityOverall official - principal investigator
- University of BresciaOverall official - principal investigator
- University of LausanneOverall official - principal investigator
- Ballinasloe co Galway (Ireland)Overall official - principal investigator
- University of BarcelonaOverall official - principal investigator
- Jagiellonian UniversityOverall official - principal investigator
- Katholieke Universiteit LeuvenOverall official - principal investigator
- Katholieke Universiteit LeuvenStudy chair
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
- Medical University of GdanskOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.